Ofloxacin Stulln

Ofloxacin, the active ingredient in Ofloxacin Stulln, is a fluoroquinolone antibiotic presented as a unknown strength/unknown form for ocular use. It treats bacterial eye infections in patients requiring topical therapy.

GNH USA supplies Ofloxacin Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin Stulln is a fluoroquinolone that targets bacterial pathogens in ocular tissues. - Bacterial conjunctivitis: Reduces bacterial load and alleviates redness and discharge. - Keratitis: Helps eradicate the infection and promotes corneal healing. - Blepharitis: Controls bacterial overgrowth contributing to eyelid inflammation.

Ocular administration of Ofloxacin may cause local and systemic reactions.

Common Side Effects: - Burning sensation - Stinging - Temporary blurred vision - Tearing - Redness of the eye - Mild eye irritation

Serious or Rare Side Effects: - Corneal ulceration - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome - Toxic epidermal necrolysis - Persistent visual loss - Secondary eye infection

When using Ofloxacin Stulln, follow standard safety measures and monitor for adverse reactions. - Allergy assessment: Verify the patient has no known ofloxacin or fluoroquinolone hypersensitivity. - Contact lens wearers: Advise to remove lenses before instillation and avoid re‑insertion until symptoms subside. - Duration of therapy: Limit treatment to the prescribed course to prevent resistance. - Pediatric use: Use only if prescribed by a qualified eye care specialist. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Ofloxacin may interact with other medications administered systemically or topically.

Major Interactions (​A​) :  - Caffeine : Increases the risk of central nervous system stimulation effects such as t t t. - ");

Major Interaction ( "); 

   "  " "); " " ",